Hongyuan Pharmaceutical: Net loss of 5.8104 million yuan in the first half of 2025.

Hongyuan Pharmaceutical announced that the business revenue in the first half of 2025 was 883 million yuan, a year-on-year decrease of 1.73%. Net loss was 5.81 million yuan, compared to a net profit of 35.81 million yuan in the same period last year.